Skip to Main content Skip to Navigation
Journal articles

Using CRISPR-Cas systems as antimicrobials

Abstract : Although CRISPR-Cas systems naturally evolved to provide adaptive immunity in bacteria and archaea, Cas nucleases can be co-opted to target chromosomal sequences rather than invasive genetic elements. Although genome editing is the primary outcome of self-targeting using CRISPR-based technologies in eukaryotes, self-targeting by CRISPR is typically lethal in bacteria. Here, we discuss how DNA damage introduced by Cas nucleases in bacteria can efficiently and specifically lead to plasmid curing or drive cell death. Specifically, we discuss how various CRISPR-Cas systems can be engineered and delivered using phages or phagemids as vectors. These principles establish CRISPR-Cas systems as potent and programmable antimicrobials, and open new avenues for the development of CRISPR-based tools for selective removal of bacterial pathogens and precise microbiome composition alteration.
Document type :
Journal articles
Complete list of metadatas

Cited literature [63 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01911231
Contributor : David Bikard <>
Submitted on : Friday, November 2, 2018 - 3:14:43 PM
Last modification on : Monday, January 13, 2020 - 5:08:19 PM
Long-term archiving on: : Sunday, February 3, 2019 - 12:57:50 PM

File

version_final_depot_archive.pd...
Files produced by the author(s)

Identifiers

Collections

Citation

David Bikard, Rodolphe Barrangou. Using CRISPR-Cas systems as antimicrobials. Current Opinion in Microbiology, Elsevier, 2017, 37, pp.155 - 160. ⟨10.1016/j.mib.2017.08.005⟩. ⟨pasteur-01911231⟩

Share

Metrics

Record views

495

Files downloads

4517